Classifying Mood Symptom Trajectories in Adolescents With Bipolar Disorder.

early-onset euthymic latent class growth analysis quality of life recovery

Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
03 2020
Historique:
received: 14 01 2019
revised: 08 03 2019
accepted: 23 04 2019
pubmed: 1 6 2019
medline: 19 3 2021
entrez: 1 6 2019
Statut: ppublish

Résumé

The Course and Outcome of Bipolar Youth study found that children and adolescents with bipolar spectrum disorders followed 1 of 4 distinct mood trajectories over 8 years of follow-up, with as many as 25% of participants showing a predominantly euthymic course. We evaluated whether similar patterns of illness course are observed in adolescents with bipolar I and II disorder who participated in a 2-year clinical trial. A total of 144 adolescents with bipolar I or II disorder, identified shortly after a mood episode, were assessed over a 2-year period. Participants were randomly assigned to one of 2 psychosocial family treatments during the first 9 months of the study, and pharmacotherapy was provided throughout the 2 years. Using latent class growth analyses, we classified participants into distinct courses of illness based on mood ratings collected over the 2 years. We examined demographic and illness variables as predictors of these course classifications. Latent class growth analyses indicated four mood trajectories: "predominantly euthymic" (29.9% of sample), "ill with significantly improving course" (11.1%), "moderately euthymic" (26.4%), and "ill with moderately improving course" (32.6%). Adolescents in these classes were euthymic 77.7%, 53.6%, 44.1%, and 18.6% of the weeks of follow-up, respectively. Psychosocial treatment condition and baseline medication exposure were not associated with trajectories. However, youth with more severe baseline depressive symptoms, suicidality, lower quality of life scores, and minority race/ethnicity had more symptomatic courses of illness over time. A substantial proportion (25%-30%) of youth with bipolar I or II disorder maintain euthymic states over extended periods of follow-up. Identifying youth who are more and less likely to remain stable over time may help guide psychosocial and pharmacological treatments after an illness episode. Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents; https://clinicaltrials.gov/; NCT00332098.

Identifiants

pubmed: 31150753
pii: S0890-8567(19)30356-9
doi: 10.1016/j.jaac.2019.04.028
pmc: PMC6881540
mid: NIHMS1530302
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT00332098']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-390

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH074033
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH073871
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH093676
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH077856
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH073817
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH123575
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH117200
Pays : United States

Informations de copyright

Copyright © 2019 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

Am J Psychiatry. 2004 Aug;161(8):1447-54
pubmed: 15285972
J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):213-35
pubmed: 15725966
Biol Psychiatry. 2000 Sep 15;48(6):445-57
pubmed: 11018218
Compr Psychiatry. 2012 Feb;53(2):125-9
pubmed: 21550033
Arch Gen Psychiatry. 2004 May;61(5):459-67
pubmed: 15123490
Arch Gen Psychiatry. 1992 Feb;49(2):126-31
pubmed: 1550465
Am J Psychiatry. 2006 Sep;163(9):1633-6
pubmed: 16946191
Biol Psychiatry. 2004 May 1;55(9):875-81
pubmed: 15110730
Schizophr Bull. 1977;3(2):246-58
pubmed: 329407
J Abnorm Psychol. 2009 Aug;118(3):431-47
pubmed: 19685942
J Affect Disord. 2000 Apr;58(1):79-86
pubmed: 10760562
Arch Gen Psychiatry. 2002 Jun;59(6):530-7
pubmed: 12044195
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Arch Gen Psychiatry. 1987 Jun;44(6):540-8
pubmed: 3579500
Bipolar Disord. 2010 Mar;12(2):116-41
pubmed: 20402706
Am J Psychiatry. 2007 Feb;164(2):201-4
pubmed: 17267779
Bipolar Disord. 2009 Jun;11(4):391-400
pubmed: 19500092
J Affect Disord. 2000 Aug;59(2):107-17
pubmed: 10837879
Arch Gen Psychiatry. 2000 Jul;57(7):675-82
pubmed: 10891038
J Clin Psychiatry. 2010 Jul;71(7):864-72
pubmed: 20667291
Am J Psychiatry. 2009 Jul;166(7):795-804
pubmed: 19448190
Psychiatry Res. 1986 Mar;17(3):203-12
pubmed: 3704028
Am J Psychiatry. 2014 Jun;171(6):658-67
pubmed: 24626789
J Consult Clin Psychol. 2003 Jun;71(3):482-92
pubmed: 12795572
Psychiatry Res. 2009 Aug 15;168(3):186-92
pubmed: 19573929
Health Qual Life Outcomes. 2005 Nov 15;3:72
pubmed: 16288650
Arch Gen Psychiatry. 2012 May;69(5):515-28
pubmed: 22213771
J Child Adolesc Psychopharmacol. 2003 Winter;13(4):463-70
pubmed: 14977459
Arch Gen Psychiatry. 2006 Feb;63(2):175-83
pubmed: 16461861
Am J Psychiatry. 2014 Sep;171(9):990-9
pubmed: 24874203
J Affect Disord. 2004 Nov 1;82(3):343-52
pubmed: 15555685
J Clin Psychol Med Settings. 2017 Dec;24(3-4):187-210
pubmed: 28900779
Arch Gen Psychiatry. 1985 Jul;42(7):696-702
pubmed: 4015311
Am J Psychiatry. 1997 Nov;154(11):1544-50
pubmed: 9356562
Biol Psychiatry. 2000 Sep 15;48(6):458-66
pubmed: 11018219
Am J Psychiatry. 2009 Feb;166(2):173-81
pubmed: 19122008
Am J Psychiatry. 2007 Apr;164(4):582-90
pubmed: 17403971
Health Aff (Millwood). 2016 Jun 1;35(6):1017-21
pubmed: 27269017
Arch Gen Psychiatry. 1998 Jun;55(6):547-52
pubmed: 9633674
Arch Gen Psychiatry. 2008 Oct;65(10):1125-33
pubmed: 18838629

Auteurs

Marc J Weintraub (MJ)

Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles. Electronic address: mjweintraub@mednet.ucla.edu.

Christopher D Schneck (CD)

School of Medicine, the University of Colorado, Aurora.

David A Axelson (DA)

Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus.

Boris Birmaher (B)

University of Pittsburgh Medical Center, PA.

Robert A Kowatch (RA)

Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus.

David J Miklowitz (DJ)

Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH